IGBA releases first global Intellectual Property and Competition Report
IGBA report outlines market practices delaying access to generic and biosimilar medicines
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
generics
Yugal Sikri outlines 3 key trends defining India’s pharma growth in 2025
Market consolidation, AI-driven innovation, and supportive government policies are set to propel India's pharma industry toward…
Challenges in procurement of “Quality Assured” generics
Dr Suresh Saravdekar, Ex-Assistant Director, Ministry of Medical Education and Health, State of Maharashtra and Ex-honorary…
New study shows novel strategy to improve quality checking of generic drugs
The strategy is likely to improve the regulatory and decision-making aspects related to pharmaceutical products
Pfizer to allow generic COVID pill in 95 countries
There is no patent yet on the experimental candidate PF-07321332, and ritonavir has been off-patent since last year
Biocon expands its generic formulations, launches Everolimus tablets in US
Everolimus (Afinitor) is a prescription medication that is used to treat certain types of cancers and tumours
BDR Pharmaceuticals set to launch maiden generic Cabozantinib to treat metastatic medullary thyroid…
The company is amongst the first to receive permission from DCGI and launch the drug in India
Sun Pharma announces settlement of patent litigation for generic Revlimid in the US
Pursuant to the terms of the settlement, Celgene will grant Sun Pharma a license to Celgene’s patents required to manufacture…
To accelerate recovery of pharma ancillary industry, primary focus should be financial relief to…
Rishabh Bindlish, MD, India Life Sciences and Global Generics Lead, Accenture in India talks about the measures needed to revive…
Indian pharma industry is strategically placed to cater to the COVID-19 crisis
Abhinav Bhatia, Enterprise Ireland’s recently appointed Director for India and South Asian regions highlights the benefits and…